Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AFAP1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MTHFD2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTTG3P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PDZRN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADPRH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNLY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLEC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALOX15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYB5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01198 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOLR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on